Dr Ksh Manglem SinghWorld Diabetes Day is celebrated on 14 November each year to draw attention to issues of utmost importance to the diabetes community. This year, 2024, the World Diabetes Day theme ...

Nordic Bioscience, a leading biomarker company, announced that its CPa9-HNE biomarker assay received a Letter of Support (LoS) from the U.S. Food and Drug Administration (FDA). "This trifecta of ...

Continued enrollment and dose escalation in Phase 1 study of VIP943, a potentially best-in-class anti-CD123 antibody-drug conjugate (ADC); additional data expected by early 2025 Completed Phase ...

Gilead Sciences, Inc. today presented the first in-depth look at full results from its pivotal Phase 3 PURPOSE 2 trial (NCT04925752), which is studying twice-yearly lenacapavir, the company's ...

Prevention research presented at HIV Glasgow will also include a systematic review and meta-analysis of real-world data mapping HIV prevalence against PrEP uptake, health economic data ... components ...

Researchers map the unique genetic regulation of proteins in human cerebrospinal fluid, identifying potential targets for ...

In a recent study published in Nature Communications, scientists at the Department of Microbiology, Tumor and Cell Biology at ...

Robert F. Kennedy Jr., who is lined up to advise the incoming Trump administration on its health policy agenda, has floated broad plans to “make America healthy again.” But how he will ...

Maintaining Health and Safety Protocols Prime remains engaged with local ... with detection by inductively coupled plasma emission spectrometer for a full suite of elements. Gold assay techniques ...

Advanced biochemical assays (immunoblotting, reverse transcription polymerase chain reaction [RT-PCR], plasma corticosterone ...

Patients with advanced DLB – in whom there is significant, irreversible neuronal loss in the hippocampus and associated Alzheimer’s Disease co-pathology – as assessed by a blood biomarker (plasma ...

Spanish drugmaker Grifols said on Thursday it was on track to meet its targets for the year after its net profit fell 7.5% in the third quarter from the same period a year ago.